Here are two (2) interesting cases involving recent ANDA litigation. The first involves AstraZeneca's BRILINTA:

AstraZeneca sues Taro in blood-thinning drug patent dispute

‍

The second involves Otsuka's REXULTI:

Otsuka says Teva’s REXULTI generic infringes patents

‍

‍